Literature DB >> 2362265

Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives.

H Sugimoto1, Y Tsuchiya, H Sugumi, K Higurashi, N Karibe, Y Iimura, A Sasaki, Y Kawakami, T Nakamura, S Araki.   

Abstract

A series of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives was synthesized and evaluated for anti-acetylcholinesterase (anti-AChE) activity. Substituting the benzamide with a bulky moiety in the para position led to a substantial increase in activity. Introduction of an akyl or phenyl group at the nitrogen atom of benzamide dramatically enhanced the activity. The basic quality of the nitrogen atom of piperidine appears to play an important role in the increased activity, since the N-benzoylpiperidine derivative was almost inactive. We found that 1-benzyl-4-[2-(N-[4'-(benzylsulfonyl) benzoyl]-N-methylamino]ethyl]piperidine hydrochloride (21) (IC50 = 0.56 nM) is one of the most potent inhibitors of acetylcholinesterase. Compound 21 showed an affinity 18,000 times greater for AChE than for BuChE. At a dose of 3 mg/kg, 21 produced a marked and significant increase in acetylcholine (ACh) content in the cerebral vortex and hippocampus of rats. Compound 21 was chosen for advanced development as an antidementia agent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2362265     DOI: 10.1021/jm00169a008

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Automated docking of 82 N-benzylpiperidine derivatives to mouse acetylcholinesterase and comparative molecular field analysis with 'natural' alignment.

Authors:  P Bernard; D B Kireev; J R Chrétien; P L Fortier; L Coppet
Journal:  J Comput Aided Mol Des       Date:  1999-07       Impact factor: 3.686

2.  Molecular fingerprint-based artificial neural networks QSAR for ligand biological activity predictions.

Authors:  Kyaw-Zeyar Myint; Lirong Wang; Qin Tong; Xiang-Qun Xie
Journal:  Mol Pharm       Date:  2012-08-31       Impact factor: 4.939

3.  Ligand biological activity predictions using fingerprint-based artificial neural networks (FANN-QSAR).

Authors:  Kyaw Z Myint; Xiang-Qun Xie
Journal:  Methods Mol Biol       Date:  2015

4.  An evaluation of the pharmacokinetics of donepezil HCl in patients with moderately to severely impaired renal function.

Authors:  P J Tiseo; K Foley; L T Friedhoff
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

5.  Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.

Authors:  Jin-Shuai Lan; Jian-Wei Hou; Yun Liu; Yue Ding; Yong Zhang; Ling Li; Tong Zhang
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

6.  Classification of drug molecules considering their IC50 values using mixed-integer linear programming based hyper-boxes method.

Authors:  Pelin Armutlu; Muhittin E Ozdemir; Fadime Uney-Yuksektepe; I Halil Kavakli; Metin Turkay
Journal:  BMC Bioinformatics       Date:  2008-10-03       Impact factor: 3.169

7.  Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer's disease.

Authors:  Julien Lalut; Hugo Payan; Audrey Davis; Cédric Lecoutey; Rémi Legay; Jana Sopkova-de Oliveira Santos; Sylvie Claeysen; Patrick Dallemagne; Christophe Rochais
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

8.  Synthetic Approaches for Piperidone-Based Templates as Scaffolds to Access Chirally Enriched Donepezil Analogues.

Authors:  Anna Poeschl; David M Mountford; Robert C Hider; Agostino Cilibrizzi
Journal:  ACS Omega       Date:  2020-02-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.